Pharma Journalist -

Hope Biosciences announced that FDA has approved a Phase II clinical trial evaluating the safety and efficacy of Hope Biosciences’ allogeneic, adipose-derived mesenchymal stem cells…
Read More...

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced that the US Food and Drug Administration (FDA) has approved the…
Read More...

Celltrion announced that the company has successfully selected the most potent antibody candidates to neutralize SARS-CoV-2, the virus causing COVID-19. Through a partnership with…
Read More...

Blackstone and Alnylam Pharmaceuticals, Inc. announced the companies have entered into a broad strategic collaboration under which Blackstone will provide up to $2 billion to support…
Read More...

The U.S. Food and Drug Administration approved Koselugo (selumetinib) for the treatment of pediatric patients, 2 years of age and older, with neurofibromatosis type 1 (NF1), a genetic…
Read More...

BioNTech SE and Pfizer Inc. today disclosed additional details of their collaboration to advance candidates from BioNTech’s mRNA vaccine program, previously announced on March 17, 2020.…
Read More...

NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, announced it has entered into a clinical collaboration agreement with Bristol Myers Squibb to evaluate…
Read More...

Recipharm announced that Erdosteine will be tested in a clinical study as an add-on treatment for COVID-19 patients. The clinical study, which began on 7th April, is being conducted…
Read More...

Regeneron Pharmaceuticals, Inc. and Zai Lab Limited announced a strategic collaboration for the development and commercialization of REGN1979 (CD20xCD3 bispecific antibody) in mainland…
Read More...

Avacta Group plc announced that it has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences. The companies will develop and manufacture an…
Read More...